Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape thefuture of medicine by providing a platform for expert commentary and analysis.
The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.
- Does not allow reviews to be publicly displayed
- Only allows reviewers to display the journal they reviewed for
- Does not allow reviewers to sign or publicly display reviews of rejected publications subsequently published in another journal
Interested in reviewing for this journal?
Your interest in reviewing is shared with journals or conferences when they are partnered with us. Learn more.
Editorial board members on Publons
Publons users have indicated that they sit on Personalized Medicine's editorial board but we are unable to verify these claims.
Top reviewers on Publons (Manuscripts reviewed in last 12 months)
Review contents for Personalized Medicine are not publicly displayed on Publons, in accordance with their editorial policy.